Initiates Coverage on Milestone Scientific (NYSE:MLSS)

Stock analysts at assumed coverage on shares of Milestone Scientific (NYSE:MLSSGet Rating) in a research note issued on Monday. The brokerage set a “sell” rating on the stock.

Milestone Scientific Trading Down 4.3 %

Shares of MLSS opened at $0.66 on Monday. Milestone Scientific has a 1-year low of $0.55 and a 1-year high of $2.72. The firm has a fifty day simple moving average of $0.74 and a two-hundred day simple moving average of $0.90. The firm has a market cap of $45.49 million, a PE ratio of -5.50 and a beta of 1.33.

About Milestone Scientific

(Get Rating)

Milestone Scientific Inc designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic.

Featured Stories

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with's FREE daily email newsletter.